FDA Investigator Abdur Razzaque
Abdur Razzaque has conducted inspections on 3 sites in 1 countries as of 30 Aug 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
30 Aug 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Abdur Razzaque:
Arie C Menachem,
Bharat Khurana,
Brentley S Collins,
Christian D Lynch (CDL),
Christine M Parmentier,
Cynthia Jim, CSO,
Daniel J Roberts,
Dr. Guang Gao, PhD,
Dr. Ralph M Bernstein, PhD,
Eileen A Liu,
Gene D Arcy,
Gwyn G Dickinson,
Henry K Lau,
Jacqueline Mdiaz Albertini,
James R Fleckenstein,
Jeffrey M Watson,
Joan A Loreng,
Juan A Morales,
Lakshmi Narasimhan, PhD,
Lance Mde Souza, MBA,
Lewis K Antwi,
Lydia S Chan,
Mariza M Jafary,
Mei Chiung Huang (Jo),
Mihaly S Ligmond,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Paula A Trost,
Pawan K Jain,
Prabhu P Raju,
Rebecca Rodriguez,
Simone E Pitts,
Susan M Jackson,
Tania Y Hall
Abdur Razzaque's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2010 | FDA 483 | Grifols Diagnostic Solutions Inc. - Form 483, 2010-07-15 |
May, 2011 | FDA 483 | Novartis Pharmaceuticals Corporation - Form 483, 2011-05-12 |
January, 2011 | FDA 483 | National Genetics Institute - Form 483, 2011-01-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more